首页 > 最新文献

Female Pelvic Medicine and Reconstructive Surgery最新文献

英文 中文
Joint Position Statement on Midurethral Slings for Stress Urinary Incontinence. 中尿道吊带治疗压力性尿失禁的联合立场声明。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001096
T he purpose of this Position Statement by the American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) is to support the use of the midurethral sling (MUS) for the surgical management of stress urinary incontinence (SUI). Developed in the 1990s, the MUS treats SUI in a minimally invasive, outpatient procedure. This technique uses a small mesh strip composed ofmonofilament polypropylene placed through the vagina under the midurethra and exiting from 2 small sites in either the suprapubic or groin area. They are often referred to as full-length slings to differentiate them from smaller single-incision slings or mini slings. This document refers to the full-length MUS. Stress urinary incontinence, defined as the involuntary urine leakage associated with coughing, sneezing, or other types of exertion, is prevalent, with 13.6% of women in the United States having had at least 1 surgical procedure for SUI in their lifetime, resulting in 260,000 continence surgical procedures annually. Stress urinary incontinence is often a bothersome and even debilitating condition that can substantially reduce a woman’s quality of life. Although nonsurgical treatments such as pelvic floor exercises and vaginal inserts (or pessaries) are helpful in alleviating symptoms in some women, many proceed with surgery, which is a more effective, durable treatment. In 2011, the U.S. Food and Drug Administration (FDA) issued a public health notification regarding adverse events associated with transvaginal mesh used to treat pelvic organ prolapse. In 2019, the FDA ordered the manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse to stop selling and distributing their products in the United States. The media attention and litigation surrounding these FDA announcements have resulted in confusion between transvaginal mesh used to treat pelvic organ prolapse and the MUS used to treat SUI. This may have led to a negative perception of the MUS. In 2019, the FDA reaffirmed the findings of its safety panel and literature review stating that the safety and effectiveness of the full-length MUS is well established. The FDA has not recalled or published warnings against the full-length MUS.Most experts who dealwith female SUI are supportive of the use of theMUS and the majority of women who have had one placed are satisfied.
{"title":"Joint Position Statement on Midurethral Slings for Stress Urinary Incontinence.","authors":"","doi":"10.1097/SPV.0000000000001096","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001096","url":null,"abstract":"T he purpose of this Position Statement by the American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) is to support the use of the midurethral sling (MUS) for the surgical management of stress urinary incontinence (SUI). Developed in the 1990s, the MUS treats SUI in a minimally invasive, outpatient procedure. This technique uses a small mesh strip composed ofmonofilament polypropylene placed through the vagina under the midurethra and exiting from 2 small sites in either the suprapubic or groin area. They are often referred to as full-length slings to differentiate them from smaller single-incision slings or mini slings. This document refers to the full-length MUS. Stress urinary incontinence, defined as the involuntary urine leakage associated with coughing, sneezing, or other types of exertion, is prevalent, with 13.6% of women in the United States having had at least 1 surgical procedure for SUI in their lifetime, resulting in 260,000 continence surgical procedures annually. Stress urinary incontinence is often a bothersome and even debilitating condition that can substantially reduce a woman’s quality of life. Although nonsurgical treatments such as pelvic floor exercises and vaginal inserts (or pessaries) are helpful in alleviating symptoms in some women, many proceed with surgery, which is a more effective, durable treatment. In 2011, the U.S. Food and Drug Administration (FDA) issued a public health notification regarding adverse events associated with transvaginal mesh used to treat pelvic organ prolapse. In 2019, the FDA ordered the manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse to stop selling and distributing their products in the United States. The media attention and litigation surrounding these FDA announcements have resulted in confusion between transvaginal mesh used to treat pelvic organ prolapse and the MUS used to treat SUI. This may have led to a negative perception of the MUS. In 2019, the FDA reaffirmed the findings of its safety panel and literature review stating that the safety and effectiveness of the full-length MUS is well established. The FDA has not recalled or published warnings against the full-length MUS.Most experts who dealwith female SUI are supportive of the use of theMUS and the majority of women who have had one placed are satisfied.","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"707-710"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39646943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Effect of Enhanced Recovery Protocol on Opioid Use in Pelvic Organ Prolapse Surgery. 增强恢复方案对盆腔器官脱垂手术中阿片类药物使用的影响。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001114
Allen A Mehr, Caroline Elmer-Lyon, Erin Maetzold, Catherine S Bradley, Joseph T Kowalski

Objectives: Our primary objective was to compare the total opioid use by patients undergoing apical pelvic organ prolapse surgery before and after implementation of an enhanced recovery protocol (ERP).

Methods: Participants of this ambispective cohort study included a "pre-ERP" retrospective cohort and an "ERP" cohort of patients prospectively enrolled after the full implementation of the ERP in January 2019. Demographic and clinical data were collected from the electronic record. Descriptive statistics were used for demographic variables. Total opioid use was calculated for each participant using morphine milligram equivalents (MMEs) and compared between cohorts using the Student t test.

Results: Study participants (n = 65) were similar between cohorts and had a mean (SD) age of 62.4 (9.7) years and body mass index of 28.9 (4.8), and had a median parity of 3 (interquartile range, 2-4). Comorbid conditions, assessed with the Charlson Comorbidity Index, were also similar, with a mean (SD) of 2 (2.9). Hysterectomy approach and apical procedures did not differ between groups. After ERP implementation, mean (SD) intraoperative and postoperative MMEs decreased significantly (59.4 [31.6] vs 36.9 [20.5], P < 0.01). Total MMEs prescribed at discharge also decreased (392.3 [88.4] vs 94.6 [61.3], P < 0.01). Total anesthesia time and surgical time were similar, whereas mean total admission time decreased (27.3 [10.8] vs 18 [8.6] hours, P < 0.01). Telephone calls within 30 days increased from mean 1 (1.0) to 2.2 (1.9) (P < 0.01), whereas clinic visits and 30-day readmissions did not differ.

Conclusions: Women undergoing apical pelvic organ prolapse surgery at an academic medical center received significantly fewer opioids after implementation of an ERP without a change in postoperative pain scores.

目的:我们的主要目的是比较在实施增强恢复方案(ERP)之前和之后接受根尖盆腔器官脱垂手术的患者阿片类药物的总使用量。方法:这项双视角队列研究的参与者包括一个“ERP前”回顾性队列和一个“ERP”队列,这些患者是在2019年1月ERP全面实施后前瞻性入组的。从电子记录中收集人口统计和临床数据。人口统计变量采用描述性统计。使用吗啡毫克当量(MMEs)计算每个参与者的阿片类药物总使用量,并使用学生t检验比较队列之间的差异。结果:研究参与者(n = 65)在队列之间相似,平均(SD)年龄为62.4(9.7)岁,身体质量指数为28.9(4.8),中位胎次为3(四分位数范围为2-4)。用Charlson共病指数评估的合并症情况也相似,平均(SD)为2(2.9)。子宫切除入路和根尖手术在两组间无差异。实施ERP后,术中、术后MMEs均值(SD)显著降低(59.4 [31.6]vs 36.9 [20.5], P < 0.01)。出院时处方的MMEs总数也减少(392.3[88.4]比94.6 [61.3]P < 0.01)。总麻醉时间与手术时间相似,而平均总住院时间缩短(27.3[10.8]小时比18[8.6]小时,P < 0.01)。30天内电话次数从平均1次(1.0次)增加到2.2次(1.9次)(P < 0.01),而门诊次数和30天再入院次数无差异。结论:在学术医疗中心接受根尖盆腔器官脱垂手术的女性在实施ERP后接受的阿片类药物明显减少,而术后疼痛评分没有改变。
{"title":"Effect of Enhanced Recovery Protocol on Opioid Use in Pelvic Organ Prolapse Surgery.","authors":"Allen A Mehr,&nbsp;Caroline Elmer-Lyon,&nbsp;Erin Maetzold,&nbsp;Catherine S Bradley,&nbsp;Joseph T Kowalski","doi":"10.1097/SPV.0000000000001114","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001114","url":null,"abstract":"<p><strong>Objectives: </strong>Our primary objective was to compare the total opioid use by patients undergoing apical pelvic organ prolapse surgery before and after implementation of an enhanced recovery protocol (ERP).</p><p><strong>Methods: </strong>Participants of this ambispective cohort study included a \"pre-ERP\" retrospective cohort and an \"ERP\" cohort of patients prospectively enrolled after the full implementation of the ERP in January 2019. Demographic and clinical data were collected from the electronic record. Descriptive statistics were used for demographic variables. Total opioid use was calculated for each participant using morphine milligram equivalents (MMEs) and compared between cohorts using the Student t test.</p><p><strong>Results: </strong>Study participants (n = 65) were similar between cohorts and had a mean (SD) age of 62.4 (9.7) years and body mass index of 28.9 (4.8), and had a median parity of 3 (interquartile range, 2-4). Comorbid conditions, assessed with the Charlson Comorbidity Index, were also similar, with a mean (SD) of 2 (2.9). Hysterectomy approach and apical procedures did not differ between groups. After ERP implementation, mean (SD) intraoperative and postoperative MMEs decreased significantly (59.4 [31.6] vs 36.9 [20.5], P < 0.01). Total MMEs prescribed at discharge also decreased (392.3 [88.4] vs 94.6 [61.3], P < 0.01). Total anesthesia time and surgical time were similar, whereas mean total admission time decreased (27.3 [10.8] vs 18 [8.6] hours, P < 0.01). Telephone calls within 30 days increased from mean 1 (1.0) to 2.2 (1.9) (P < 0.01), whereas clinic visits and 30-day readmissions did not differ.</p><p><strong>Conclusions: </strong>Women undergoing apical pelvic organ prolapse surgery at an academic medical center received significantly fewer opioids after implementation of an ERP without a change in postoperative pain scores.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"e705-e709"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900056/pdf/nihms-1782839.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39646948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Relationship of Pain Catastrophizing With Urinary Biomarkers in Women With Bladder Pain Syndrome. 膀胱疼痛综合征女性疼痛加重与尿液生物标志物的关系
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001041
Alex Soriano, Antoinette Allen, Anna P Malykhina, Uduak Andy, Heidi Harvie, Lily Arya

Objectives: Brain-derived neurotrophic factor (BDNF) has been implicated in central neurological processes. We hypothesize that greater pain catastrophizing is associated with higher urinary BDNF levels in women with bladder pain syndrome.

Methods: A secondary analysis of a database of women with urinary urgency was conducted. We identified women who met AUA criteria of bladder pain syndrome. Urinary symptoms, pain catastrophizing, and neuropathic pain were measured using the Female Genitourinary Pain Index, Pain Catastrophizing Scale and painDETECT questionnaires respectively. The relationship of the catastrophizing score with urinary BDNF (primary outcome) and other urinary biomarkers, including nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and osteopontin, was evaluated using univariable and multivariable analyses.

Results: In 62 women with bladder pain syndrome, 15 (24%) reported pain catastrophizing symptoms (Pain Catastrophizing Scale score >30). Higher catastrophizing scores were associated with worse urinary symptoms, greater pelvic pain, greater neuropathic pain, and worse quality of life scores (all P < 0.01). On multivariable analysis, after controlling for age, body mass index and urinary symptoms, a higher pain catastrophizing score was associated with lower BDNF (P = 0.04) and lower VEGF levels (P = 0.03). Urinary urgency was associated with a higher NGF level (P = 0.04) while bladder pain was associated with higher levels of NGF (P = 0.03) and VEGF (P = 0.01).

Conclusions: Neuroinflammatory mechanisms contribute to the central processing of pain in women with bladder pain syndrome. Worse urinary symptoms are associated with higher NGF and VEGF levels, but worse pain catastrophizing is associated with lower BDNF and VEGF levels. Urinary BDNF levels may be useful in phenotyping women who have central augmentation of pain processing.

目的:脑源性神经营养因子(BDNF)参与中枢神经过程。我们假设,在患有膀胱疼痛综合征的女性中,更大的疼痛灾难化与更高的尿BDNF水平有关。方法:对尿急妇女数据库进行二次分析。我们确定了符合AUA膀胱疼痛综合征标准的女性。分别采用女性泌尿生殖系统疼痛指数、疼痛加重量表和painDETECT问卷对泌尿系统症状、疼痛加重和神经性疼痛进行测量。灾难化评分与尿BDNF(主要结局)和其他尿液生物标志物(包括神经生长因子(NGF)、血管内皮生长因子(VEGF)和骨桥蛋白)的关系通过单变量和多变量分析进行评估。结果:62例膀胱疼痛综合征患者中,15例(24%)报告有疼痛加重症状(疼痛加重量表评分>30)。较高的灾难化评分与更严重的泌尿系统症状、更严重的盆腔疼痛、更严重的神经性疼痛和更差的生活质量评分相关(均P < 0.01)。在多变量分析中,在控制年龄、体重指数和泌尿系统症状后,较高的疼痛灾难评分与较低的BDNF (P = 0.04)和较低的VEGF水平相关(P = 0.03)。尿急与较高的NGF水平相关(P = 0.04),膀胱疼痛与较高的NGF (P = 0.03)和VEGF水平相关(P = 0.01)。结论:神经炎症机制参与了膀胱疼痛综合征女性疼痛的中枢加工。更严重的泌尿系统症状与更高的NGF和VEGF水平有关,但更严重的疼痛灾难与更低的BDNF和VEGF水平有关。尿BDNF水平可能对疼痛处理中枢增强的女性表型分析有用。
{"title":"Relationship of Pain Catastrophizing With Urinary Biomarkers in Women With Bladder Pain Syndrome.","authors":"Alex Soriano,&nbsp;Antoinette Allen,&nbsp;Anna P Malykhina,&nbsp;Uduak Andy,&nbsp;Heidi Harvie,&nbsp;Lily Arya","doi":"10.1097/SPV.0000000000001041","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001041","url":null,"abstract":"<p><strong>Objectives: </strong>Brain-derived neurotrophic factor (BDNF) has been implicated in central neurological processes. We hypothesize that greater pain catastrophizing is associated with higher urinary BDNF levels in women with bladder pain syndrome.</p><p><strong>Methods: </strong>A secondary analysis of a database of women with urinary urgency was conducted. We identified women who met AUA criteria of bladder pain syndrome. Urinary symptoms, pain catastrophizing, and neuropathic pain were measured using the Female Genitourinary Pain Index, Pain Catastrophizing Scale and painDETECT questionnaires respectively. The relationship of the catastrophizing score with urinary BDNF (primary outcome) and other urinary biomarkers, including nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and osteopontin, was evaluated using univariable and multivariable analyses.</p><p><strong>Results: </strong>In 62 women with bladder pain syndrome, 15 (24%) reported pain catastrophizing symptoms (Pain Catastrophizing Scale score >30). Higher catastrophizing scores were associated with worse urinary symptoms, greater pelvic pain, greater neuropathic pain, and worse quality of life scores (all P < 0.01). On multivariable analysis, after controlling for age, body mass index and urinary symptoms, a higher pain catastrophizing score was associated with lower BDNF (P = 0.04) and lower VEGF levels (P = 0.03). Urinary urgency was associated with a higher NGF level (P = 0.04) while bladder pain was associated with higher levels of NGF (P = 0.03) and VEGF (P = 0.01).</p><p><strong>Conclusions: </strong>Neuroinflammatory mechanisms contribute to the central processing of pain in women with bladder pain syndrome. Worse urinary symptoms are associated with higher NGF and VEGF levels, but worse pain catastrophizing is associated with lower BDNF and VEGF levels. Urinary BDNF levels may be useful in phenotyping women who have central augmentation of pain processing.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"746-752"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449794/pdf/nihms-1660463.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25533637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Racial and Ethnic Disparities in Obliterative Procedures for the Treatment of Vaginal Prolapse. 阴道脱垂手术的种族和民族差异。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001116
William D Winkelman, Michele R Hacker, Malika Anand, Roger Lefevre, Monica L Richardson

Objectives: Although racial disparities are well documented for common gynecologic surgical procedures, few studies have assessed racial disparities in the surgical treatment of vaginal prolapse. This study aimed to compare the use of obliterative procedures for the treatment of vaginal prolapse across racial and ethnic groups.

Study design: This is a retrospective cohort study of surgical cases from 2010 to 2018 from the American College of Surgeons National Surgical Quality Improvement Program, a nationally validated database. Cases were identified by Current Procedural Terminology codes. Modified Poisson regression was used to calculate risk ratios and 95% confidence intervals, adjusting for potential confounders selected a priori.

Results: We identified 45,865 surgical cases, of which 10% involved an obliterative procedure. In the unadjusted model, non-Hispanic Asian and non-Hispanic Black patients were more likely to undergo an obliterative procedure compared with non-Hispanic White patients (risk ratio [95% confidence interval], 2.4 [2.1-2.7] and 1.2 [1.03-1.3], respectively). These relative risks were largely unchanged when controlling for age, body mass index, diabetes, American Society of Anesthesiologists classification, and concurrent hysterectomy.

Conclusions: Although both obliterative and reconstructive procedures have their respective risks and benefits, the proportion of patients undergoing each procedure differs by race and ethnicity. It is unclear whether such disparities may be attributable to differences in preference or inequity in care.

目的:虽然种族差异在常见的妇科手术中有很好的记录,但很少有研究评估阴道脱垂手术治疗中的种族差异。本研究的目的是比较不同种族和民族的人在治疗阴道脱垂时使用切除手术的情况。研究设计:这是一项回顾性队列研究,从2010年到2018年的手术病例,来自美国外科医师学会国家手术质量改进计划,这是一个经过全国验证的数据库。个案由现行程序术语守则厘定。采用修正泊松回归计算风险比和95%置信区间,对先验选择的潜在混杂因素进行调整。结果:我们确定了45,865例手术病例,其中10%涉及闭塞手术。在未调整的模型中,与非西班牙裔白人患者相比,非西班牙裔亚裔和非西班牙裔黑人患者更有可能接受闭塞手术(风险比分别为[95%置信区间],2.4[2.1-2.7]和1.2[1.03-1.3])。在控制年龄、体重指数、糖尿病、美国麻醉医师学会分类和同时切除子宫等因素后,这些相对风险基本不变。结论:虽然闭塞和重建手术都有各自的风险和益处,但接受每种手术的患者比例因种族和民族而异。目前尚不清楚这种差异是否可归因于偏好差异或护理不平等。
{"title":"Racial and Ethnic Disparities in Obliterative Procedures for the Treatment of Vaginal Prolapse.","authors":"William D Winkelman,&nbsp;Michele R Hacker,&nbsp;Malika Anand,&nbsp;Roger Lefevre,&nbsp;Monica L Richardson","doi":"10.1097/SPV.0000000000001116","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001116","url":null,"abstract":"<p><strong>Objectives: </strong>Although racial disparities are well documented for common gynecologic surgical procedures, few studies have assessed racial disparities in the surgical treatment of vaginal prolapse. This study aimed to compare the use of obliterative procedures for the treatment of vaginal prolapse across racial and ethnic groups.</p><p><strong>Study design: </strong>This is a retrospective cohort study of surgical cases from 2010 to 2018 from the American College of Surgeons National Surgical Quality Improvement Program, a nationally validated database. Cases were identified by Current Procedural Terminology codes. Modified Poisson regression was used to calculate risk ratios and 95% confidence intervals, adjusting for potential confounders selected a priori.</p><p><strong>Results: </strong>We identified 45,865 surgical cases, of which 10% involved an obliterative procedure. In the unadjusted model, non-Hispanic Asian and non-Hispanic Black patients were more likely to undergo an obliterative procedure compared with non-Hispanic White patients (risk ratio [95% confidence interval], 2.4 [2.1-2.7] and 1.2 [1.03-1.3], respectively). These relative risks were largely unchanged when controlling for age, body mass index, diabetes, American Society of Anesthesiologists classification, and concurrent hysterectomy.</p><p><strong>Conclusions: </strong>Although both obliterative and reconstructive procedures have their respective risks and benefits, the proportion of patients undergoing each procedure differs by race and ethnicity. It is unclear whether such disparities may be attributable to differences in preference or inequity in care.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"e710-e715"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812327/pdf/nihms-1745924.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39735785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Reply: Hysterectomy Versus Hysteropexy at the Time of Native-Tissue Pelvic Organ Prolapse Repair: A Cost-Effectiveness Analysis. 回复:子宫切除术与子宫切除术在原位组织盆腔器官脱垂修复时:成本-效果分析。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001117
Olivia H Chang, Jonathan P Shepherd, Beri M Ridgeway, Lauren A Cadish
{"title":"Reply: Hysterectomy Versus Hysteropexy at the Time of Native-Tissue Pelvic Organ Prolapse Repair: A Cost-Effectiveness Analysis.","authors":"Olivia H Chang,&nbsp;Jonathan P Shepherd,&nbsp;Beri M Ridgeway,&nbsp;Lauren A Cadish","doi":"10.1097/SPV.0000000000001117","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001117","url":null,"abstract":"","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"e716"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39735786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Preparedness for Pelvic Organ Prolapse Surgery: A Randomized Equivalence Trial of Preoperative Counseling. 盆腔器官脱垂手术的患者准备:术前咨询的随机等效试验。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001049
Jessica C Sassani, Philip J Grosse, Lauren Kunkle, Lindsey Baranski, Mary F Ackenbom

Objective: Preoperative counseling can affect postoperative outcomes and satisfaction. We hypothesized that patient preparedness would be equivalent after preoperative counseling phone calls versus preoperative counseling office visits before prolapse surgery.

Methods: This was an equivalence randomized controlled trial of women undergoing pelvic organ prolapse surgery. Participants were randomized to receive standardized counseling via a preoperative phone call or office visit. The primary outcome was patient preparedness measured on a 5-point Likert scale by the Patient Preparedness Questionnaire at the postoperative visit. A predetermined equivalence margin of 20% was used. Two 1-sided tests for equivalence were used for the primary outcome.

Results: We randomized 120 women. The study was concluded early because of COVID-19 and subsequent surgery cancellations. There were 85 participants with primary outcome data (43 offices, 42 phones). Mean age was 62.0 years (±1.0) and 64 (75.3%) had stage III or stage IV prolapse. The primary outcome, patient preparedness measured at the postoperative visit, was equivalent between groups (office, n = 43 [97.7%]; phone, n = 42 [97.6%], P < 0.001). Most women reported they would have preferred a phone call (n = 66, 65.5%) with more women in the phone group expressing this preference than the office group (office 40.5% vs phone 90.5%, P < 0.001). Ultimately, nearly all women (96.5%) were satisfied with their method of counseling.

Conclusions: Preoperative counseling phone calls were equivalent to office visits for patient preparedness for pelvic organ prolapse surgery. This study demonstrates patient acceptance of phone calls for preoperative counseling. Telehealth modalities should be considered as an option for preoperative patient counseling.

目的:术前咨询可影响术后预后和满意度。我们假设患者在术前咨询电话与术前咨询办公室访问脱垂手术前的准备是相同的。方法:这是一项接受盆腔器官脱垂手术的妇女的等效随机对照试验。参与者通过术前电话或办公室访问随机接受标准化咨询。主要结果是术后就诊时患者准备问卷以5分李克特量表测量患者准备情况。预定等效余量为20%。主要结局采用了两个单侧等效检验。结果:我们随机选择了120名女性。由于COVID-19和随后的手术取消,该研究提前结束。85名参与者获得了主要结局数据(43个办公室,42个电话)。平均年龄62.0岁(±1.0岁),64例(75.3%)为III期或IV期脱垂。主要结局,术后访视时测量的患者准备情况,两组之间相同(office, n = 43 [97.7%];电话,n = 42 [97.6%], P < 0.001)。大多数女性报告说她们更喜欢打电话(n = 66, 65.5%),在电话组中表达这种偏好的女性多于办公室组(办公室40.5%比电话90.5%,P < 0.001)。最终,几乎所有的女性(96.5%)对她们的咨询方法感到满意。结论:对于盆腔器官脱垂手术的患者,术前咨询电话等同于办公室拜访。本研究表明患者接受电话术前咨询。远程医疗模式应被视为术前患者咨询的一种选择。
{"title":"Patient Preparedness for Pelvic Organ Prolapse Surgery: A Randomized Equivalence Trial of Preoperative Counseling.","authors":"Jessica C Sassani,&nbsp;Philip J Grosse,&nbsp;Lauren Kunkle,&nbsp;Lindsey Baranski,&nbsp;Mary F Ackenbom","doi":"10.1097/SPV.0000000000001049","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001049","url":null,"abstract":"<p><strong>Objective: </strong>Preoperative counseling can affect postoperative outcomes and satisfaction. We hypothesized that patient preparedness would be equivalent after preoperative counseling phone calls versus preoperative counseling office visits before prolapse surgery.</p><p><strong>Methods: </strong>This was an equivalence randomized controlled trial of women undergoing pelvic organ prolapse surgery. Participants were randomized to receive standardized counseling via a preoperative phone call or office visit. The primary outcome was patient preparedness measured on a 5-point Likert scale by the Patient Preparedness Questionnaire at the postoperative visit. A predetermined equivalence margin of 20% was used. Two 1-sided tests for equivalence were used for the primary outcome.</p><p><strong>Results: </strong>We randomized 120 women. The study was concluded early because of COVID-19 and subsequent surgery cancellations. There were 85 participants with primary outcome data (43 offices, 42 phones). Mean age was 62.0 years (±1.0) and 64 (75.3%) had stage III or stage IV prolapse. The primary outcome, patient preparedness measured at the postoperative visit, was equivalent between groups (office, n = 43 [97.7%]; phone, n = 42 [97.6%], P < 0.001). Most women reported they would have preferred a phone call (n = 66, 65.5%) with more women in the phone group expressing this preference than the office group (office 40.5% vs phone 90.5%, P < 0.001). Ultimately, nearly all women (96.5%) were satisfied with their method of counseling.</p><p><strong>Conclusions: </strong>Preoperative counseling phone calls were equivalent to office visits for patient preparedness for pelvic organ prolapse surgery. This study demonstrates patient acceptance of phone calls for preoperative counseling. Telehealth modalities should be considered as an option for preoperative patient counseling.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"719-725"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601145/pdf/nihms-1666443.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25533638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Assessment of the Pelvic Floor and Associated Musculoskeletal System: Guide for Medical Practitioners. 骨盆底和相关肌肉骨骼系统的评估:医生指南。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-12-01 DOI: 10.1097/SPV.0000000000001121
Ingrid Harm-Ernandes, Valerie Boyle, Dee Hartmann, Colleen M Fitzgerald, Jerry L Lowder, Rhonda Kotarinos, Emily Whitcomb

Objectives: This study aimed to assist practitioners in performing an accurate assessment of the external and internal pelvic musculoskeletal (MSK) systems to improve appropriate diagnosis and referral of patients with pelvic floor disorders or pelvic pain and to improve understanding of physical therapy (PT) treatment principles, thereby improving communication between practitioners and encouraging a multidisciplinary approach.

Methods: A referenced review of the anatomy of the pelvic floor muscles, pelvis, and surrounding structures, followed by a detailed assessment of anatomy, posture, and gait, is presented. A thorough description of PT assessment and treatment is included with clinical relevance.

Results: When proper assessments are routinely performed, MSK conditions can be recognized, allowing for prompt and appropriate referrals to PT. Assessment and treatment by qualified physical therapists are integral to pelvic health care. After efficient medical assessment, MSK dysfunction can be addressed expeditiously, thereby avoiding further decline. Left unaddressed, pelvic dysfunction may become chronic.

Conclusions: We propose a guide for MSK assessment of the pelvis and associated structures that can be used for both clinical and research purposes. This guide is designed for health care providers caring for women with pelvic floor disorders, including physicians, advanced practice providers, and nurses. This guide serves to improve communication among multidisciplinary practitioners to refine MSK assessment and treatment approaches and thereby advance clinical care and research.

目的:本研究旨在帮助从业人员对骨盆内外肌肉骨骼(MSK)系统进行准确评估,以改善盆底疾病或盆腔疼痛患者的适当诊断和转诊,并提高对物理治疗(PT)治疗原则的理解,从而改善从业人员之间的沟通,鼓励多学科方法。方法:对骨盆底肌肉、骨盆和周围结构的解剖进行参考回顾,然后对解剖、姿势和步态进行详细评估。PT评估和治疗的全面描述包括与临床相关。结果:当常规进行适当的评估时,可以识别MSK状况,允许及时和适当的转介到PT。由合格的物理治疗师进行评估和治疗是盆腔保健不可或缺的一部分。经过有效的医疗评估,MSK功能障碍可以迅速解决,从而避免进一步下降。如果不加以解决,盆腔功能障碍可能会变成慢性的。结论:我们提出了骨盆及相关结构MSK评估指南,可用于临床和研究目的。本指南是为照顾患有盆底疾病的妇女的卫生保健提供者设计的,包括医生、高级实践提供者和护士。本指南旨在改善多学科从业者之间的沟通,以完善MSK评估和治疗方法,从而推进临床护理和研究。
{"title":"Assessment of the Pelvic Floor and Associated Musculoskeletal System: Guide for Medical Practitioners.","authors":"Ingrid Harm-Ernandes,&nbsp;Valerie Boyle,&nbsp;Dee Hartmann,&nbsp;Colleen M Fitzgerald,&nbsp;Jerry L Lowder,&nbsp;Rhonda Kotarinos,&nbsp;Emily Whitcomb","doi":"10.1097/SPV.0000000000001121","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001121","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assist practitioners in performing an accurate assessment of the external and internal pelvic musculoskeletal (MSK) systems to improve appropriate diagnosis and referral of patients with pelvic floor disorders or pelvic pain and to improve understanding of physical therapy (PT) treatment principles, thereby improving communication between practitioners and encouraging a multidisciplinary approach.</p><p><strong>Methods: </strong>A referenced review of the anatomy of the pelvic floor muscles, pelvis, and surrounding structures, followed by a detailed assessment of anatomy, posture, and gait, is presented. A thorough description of PT assessment and treatment is included with clinical relevance.</p><p><strong>Results: </strong>When proper assessments are routinely performed, MSK conditions can be recognized, allowing for prompt and appropriate referrals to PT. Assessment and treatment by qualified physical therapists are integral to pelvic health care. After efficient medical assessment, MSK dysfunction can be addressed expeditiously, thereby avoiding further decline. Left unaddressed, pelvic dysfunction may become chronic.</p><p><strong>Conclusions: </strong>We propose a guide for MSK assessment of the pelvis and associated structures that can be used for both clinical and research purposes. This guide is designed for health care providers caring for women with pelvic floor disorders, including physicians, advanced practice providers, and nurses. This guide serves to improve communication among multidisciplinary practitioners to refine MSK assessment and treatment approaches and thereby advance clinical care and research.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 12","pages":"711-718"},"PeriodicalIF":1.6,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39646946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery: A Randomized Clinical Trial. 阴道电刺激产后神经肌肉恢复:一项随机临床试验。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-11-01 DOI: 10.1097/SPV.0000000000001037
Oluwateniola Brown, Bhumy Davé Heliker, Julia Geynisman-Tan, Meera Tavathia, Margaret G Mueller, Sarah Collins, Kimberly Kenton, Christina Lewicky-Gaupp

Objective: The aim of this study was to compare 3-month postpartum anal incontinence symptoms in women who sustain obstetric anal sphincter injuries and begin immediate vaginal electrical stimulation versus sham therapy.

Methods: In this double-blind randomized controlled trial, women who sustained obstetric anal sphincter injuries were randomized to receive self-administered vaginal electrical stimulation using a commercial device or sham therapy with an identical device. Anal incontinence symptom severity was assessed at 1 week (baseline) and again at 13 weeks postpartum using the Fecal Incontinence Severity Index. The primary outcome was anal incontinence symptom severity measured by the total Fecal Incontinence Severity Index score at 13 weeks postpartum.

Results: Between February 2016 and September 2018, 48 women completed a 13-week follow-up. At 13 weeks postpartum, median Fecal Incontinence Severity Index scores were higher (more severe) in the vaginal electrical stimulation group (12; interquartile range, 0-23) than in the sham group (4; interquartile range, 0-10) (P = 0.04). Unlike the vaginal electrical stimulation group, the improvement in Fecal Incontinence Severity Index scores in the sham group (vaginal electrical stimulation: 12 [interquartile range, 8-22] to 12 [interquartile range, 0-23] [P = 0.12] vs sham: 12 [interquartile range, 6-18] to 4.0 [interquartile range, 0-11] [P < 0.001]) met the threshold for clinical significance based on the minimum important difference of the Fecal Incontinence Severity Index.

Conclusion: At 13 weeks postpartum, women who underwent postpartum vaginal electrical stimulation reported more anal incontinence symptoms compared with those receiving sham therapy. Vaginal electrical stimulation after obstetric anal sphincter injury was not beneficial in reducing anal incontinence symptoms and may impede recovery.

目的:本研究的目的是比较产科肛门括约肌损伤并立即开始阴道电刺激与假治疗的妇女产后3个月肛门失禁症状。方法:在这项双盲随机对照试验中,持续产科肛门括约肌损伤的妇女被随机分为两组,一组使用商业设备进行阴道电刺激,另一组使用相同的设备进行假治疗。在产后1周(基线)和产后13周使用大便失禁严重程度指数评估肛门失禁症状严重程度。主要结局为产后13周肛门失禁症状严重程度,以粪便失禁严重程度指数总分衡量。结果:在2016年2月至2018年9月期间,48名女性完成了为期13周的随访。产后13周,阴道电刺激组大便失禁严重程度指数中位数得分更高(更严重)(12;四分位数范围,0-23)比假手术组(4;四分位数范围,0-10)(P = 0.04)。与阴道电刺激组不同,假手术组(阴道电刺激组:12[四分位数范围,8-22]至12[四分位数范围,0-23][P = 0.12]与假手术组:12[四分位数范围,6-18]至4.0[四分位数范围,0-11][P < 0.001])在大便失禁严重程度指数的最小重要差异基础上达到临床意义阈值。结论:产后13周,与接受假治疗的妇女相比,接受产后阴道电刺激的妇女报告了更多的肛门失禁症状。产科肛门括约肌损伤后阴道电刺激不利于减轻肛门失禁症状,并可能阻碍康复。
{"title":"Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery: A Randomized Clinical Trial.","authors":"Oluwateniola Brown,&nbsp;Bhumy Davé Heliker,&nbsp;Julia Geynisman-Tan,&nbsp;Meera Tavathia,&nbsp;Margaret G Mueller,&nbsp;Sarah Collins,&nbsp;Kimberly Kenton,&nbsp;Christina Lewicky-Gaupp","doi":"10.1097/SPV.0000000000001037","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001037","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to compare 3-month postpartum anal incontinence symptoms in women who sustain obstetric anal sphincter injuries and begin immediate vaginal electrical stimulation versus sham therapy.</p><p><strong>Methods: </strong>In this double-blind randomized controlled trial, women who sustained obstetric anal sphincter injuries were randomized to receive self-administered vaginal electrical stimulation using a commercial device or sham therapy with an identical device. Anal incontinence symptom severity was assessed at 1 week (baseline) and again at 13 weeks postpartum using the Fecal Incontinence Severity Index. The primary outcome was anal incontinence symptom severity measured by the total Fecal Incontinence Severity Index score at 13 weeks postpartum.</p><p><strong>Results: </strong>Between February 2016 and September 2018, 48 women completed a 13-week follow-up. At 13 weeks postpartum, median Fecal Incontinence Severity Index scores were higher (more severe) in the vaginal electrical stimulation group (12; interquartile range, 0-23) than in the sham group (4; interquartile range, 0-10) (P = 0.04). Unlike the vaginal electrical stimulation group, the improvement in Fecal Incontinence Severity Index scores in the sham group (vaginal electrical stimulation: 12 [interquartile range, 8-22] to 12 [interquartile range, 0-23] [P = 0.12] vs sham: 12 [interquartile range, 6-18] to 4.0 [interquartile range, 0-11] [P < 0.001]) met the threshold for clinical significance based on the minimum important difference of the Fecal Incontinence Severity Index.</p><p><strong>Conclusion: </strong>At 13 weeks postpartum, women who underwent postpartum vaginal electrical stimulation reported more anal incontinence symptoms compared with those receiving sham therapy. Vaginal electrical stimulation after obstetric anal sphincter injury was not beneficial in reducing anal incontinence symptoms and may impede recovery.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 11","pages":"659-666"},"PeriodicalIF":1.6,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39488202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Croatian Version of the 8-Item Overactive Bladder Questionnaire (OAB-V8). 克罗地亚版8项膀胱过度活动问卷(OAB-V8)的验证。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-11-01 DOI: 10.1097/SPV.0000000000001098
Mislav Mikuš, Martina Ostroški, Petrana Beljan, Magdalena Karadža, Stipe Dumančić, Marina Šprem Goldštajn, Mario Ćorić, Držislav Kalafatić, Slavko Orešković

Objectives: The present study was conducted with the aim to translate, adapt, and validate the 8-item Overactive Bladder Questionnaire (OAB-V8) in Croatia.

Methods: This study included a total of 58 female patients with OAB and 66 healthy women. The translation to Croatian followed standardized procedure. All eligible participants completed OAB-V8 at inclusion and 2 weeks after to assess test-retest reliability. Cronbach α coefficient was calculated to assess internal consistency.

Results: Our study demonstrated high internal consistency for all items at both visits (Cronbach α between 0.799 and 0.847), with stable internal consistency reliability across items during the 2-week period. However, the exception is the item "waking up at night to urinate," which significantly changed during the 2-week period. Intraclass correlation for OAB-V8 items ranged from 0.810 to 1.0, with Spearman correlations greater than 0.9 for all items (P < 0.01). There were strong significant correlations between frequency of urination during daytime and uncomfortable and sudden urge to urinate, and between nocturia and waking up at night. Discriminative validity showed statistically significant score differences between patients and the control group.

Conclusions: The Croatian version of the OAB-V8 was successfully translated, adapted, and validated so the questionnaire is now ready for use as a reliable tool for initial screening and assessing patients with OAB in everyday Croatian clinical practice.

目的:本研究的目的是翻译、改编和验证克罗地亚的8项膀胱过度活动问卷(OAB-V8)。方法:本研究共纳入58例女性OAB患者和66例健康女性。克罗地亚语的翻译遵循了标准化的程序。所有符合条件的参与者在纳入时和2周后完成OAB-V8以评估重测信度。计算Cronbach α系数评价内部一致性。结果:我们的研究显示,在两次访问中,所有项目的内部一致性很高(Cronbach α在0.799和0.847之间),在2周的时间内,各项目的内部一致性信度稳定。然而,例外的是“晚上醒来小便”,这在两周内发生了显著变化。OAB-V8项目的类内相关性为0.810 ~ 1.0,所有项目的Spearman相关性均大于0.9 (P < 0.01)。白天排尿频率与不舒服、突发性尿意、夜尿与夜间醒觉之间存在显著相关性。患者与对照组的判别效度评分差异有统计学意义。结论:克罗地亚版本的OAB- v8被成功地翻译、改编和验证,因此该问卷现在可以作为克罗地亚日常临床实践中初始筛选和评估OAB患者的可靠工具使用。
{"title":"Validation of the Croatian Version of the 8-Item Overactive Bladder Questionnaire (OAB-V8).","authors":"Mislav Mikuš,&nbsp;Martina Ostroški,&nbsp;Petrana Beljan,&nbsp;Magdalena Karadža,&nbsp;Stipe Dumančić,&nbsp;Marina Šprem Goldštajn,&nbsp;Mario Ćorić,&nbsp;Držislav Kalafatić,&nbsp;Slavko Orešković","doi":"10.1097/SPV.0000000000001098","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001098","url":null,"abstract":"<p><strong>Objectives: </strong>The present study was conducted with the aim to translate, adapt, and validate the 8-item Overactive Bladder Questionnaire (OAB-V8) in Croatia.</p><p><strong>Methods: </strong>This study included a total of 58 female patients with OAB and 66 healthy women. The translation to Croatian followed standardized procedure. All eligible participants completed OAB-V8 at inclusion and 2 weeks after to assess test-retest reliability. Cronbach α coefficient was calculated to assess internal consistency.</p><p><strong>Results: </strong>Our study demonstrated high internal consistency for all items at both visits (Cronbach α between 0.799 and 0.847), with stable internal consistency reliability across items during the 2-week period. However, the exception is the item \"waking up at night to urinate,\" which significantly changed during the 2-week period. Intraclass correlation for OAB-V8 items ranged from 0.810 to 1.0, with Spearman correlations greater than 0.9 for all items (P < 0.01). There were strong significant correlations between frequency of urination during daytime and uncomfortable and sudden urge to urinate, and between nocturia and waking up at night. Discriminative validity showed statistically significant score differences between patients and the control group.</p><p><strong>Conclusions: </strong>The Croatian version of the OAB-V8 was successfully translated, adapted, and validated so the questionnaire is now ready for use as a reliable tool for initial screening and assessing patients with OAB in everyday Croatian clinical practice.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 11","pages":"e687-e690"},"PeriodicalIF":1.6,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39425347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Postoperative Opioid Prescribing After Female Pelvic Medicine and Reconstructive Surgery. 女性盆腔内科及重建手术术后阿片类药物处方。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2021-11-01 DOI: 10.1097/SPV.0000000000001113
Krista M L Reagan, Sarah H Boyles, Taylor J Brueseke, Brian J Linder, Marcella G Willis-Gray, Sara B Cichowski, Jaime B Long

Objective: This study aimed to provide female pelvic medicine and reconstructive surgery (FPMRS) providers with evidence-based guidance on opioid prescribing following surgery.

Methods: A literature search of English language publications between January 1, 2000, and March 31, 2021, was conducted. Search terms identified reports on opioid prescribing, perioperative opioid use, and postoperative pain after FPMRS procedures. Publications were screened, those meeting inclusion criteria were reviewed, and data were abstracted. Data regarding the primary objective included the oral morphine milligram equivalents of opioid prescribed and used after discharge. Information meeting criteria for the secondary objectives was collected, and qualitative data synthesis was performed to generate evidence-based practice guidelines for prescription of opioids after FPMRS procedures.

Results: A total of 6,028 unique abstracts were identified, 452 were screened, and 198 full-text articles were assessed for eligibility. Fifteen articles informed the primary outcome, and 32 informed secondary outcomes.

Conclusions: For opioid-naive patients undergoing pelvic reconstructive surgery, we strongly recommend surgeons to provide no more than 15 tablets of opioids (roughly 112.5 morphine milligram equivalents) on hospital discharge. In cases where patients use no or little opioids in the hospital, patients may be safely discharged without postoperative opioids. Second, patient and surgical factors that may have an impact on opioid use should be assessed before surgery. Third, enhanced recovery pathways should be used to improve perioperative care, optimize pain control, and minimize opioid use. Fourth, systemic issues that lead to opioid overprescribing should be addressed. Female pelvic medicine and reconstructive surgery surgeons must aim to balance adequate postoperative pain control with individual and societal risks associated with excess opioid prescribing.

目的:本研究旨在为女性骨盆医学和重建手术(FPMRS)提供者提供术后阿片类药物处方的循证指导。方法:检索2000年1月1日至2021年3月31日英文出版物的文献。搜索词确定了关于阿片类药物处方、围手术期阿片类药物使用和FPMRS手术后术后疼痛的报告。对出版物进行筛选,对符合纳入标准的出版物进行审查,并对数据进行摘要。关于主要目标的数据包括处方和出院后使用的阿片类药物的口服吗啡毫克当量。收集符合次要目标标准的信息,并进行定性数据合成,以生成FPMRS手术后阿片类药物处方的循证实践指南。结果:共鉴定出6028篇独特摘要,筛选了452篇,评估了198篇全文文章的入选资格。15篇报道了主要结局,32篇报道了次要结局。结论:对于接受骨盆重建手术的阿片类药物新手患者,我们强烈建议外科医生在出院时提供不超过15片阿片类药物(大约112.5吗啡毫克当量)。如果患者在医院不使用或很少使用阿片类药物,患者可以在术后不使用阿片类药物的情况下安全出院。其次,术前应评估可能影响阿片类药物使用的患者和手术因素。第三,加强康复途径应用于改善围手术期护理,优化疼痛控制,并尽量减少阿片类药物的使用。第四,应解决导致阿片类药物过度处方的系统性问题。女性骨盆医学和重建外科医生必须致力于平衡足够的术后疼痛控制与过量阿片类药物处方相关的个人和社会风险。
{"title":"Postoperative Opioid Prescribing After Female Pelvic Medicine and Reconstructive Surgery.","authors":"Krista M L Reagan,&nbsp;Sarah H Boyles,&nbsp;Taylor J Brueseke,&nbsp;Brian J Linder,&nbsp;Marcella G Willis-Gray,&nbsp;Sara B Cichowski,&nbsp;Jaime B Long","doi":"10.1097/SPV.0000000000001113","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001113","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to provide female pelvic medicine and reconstructive surgery (FPMRS) providers with evidence-based guidance on opioid prescribing following surgery.</p><p><strong>Methods: </strong>A literature search of English language publications between January 1, 2000, and March 31, 2021, was conducted. Search terms identified reports on opioid prescribing, perioperative opioid use, and postoperative pain after FPMRS procedures. Publications were screened, those meeting inclusion criteria were reviewed, and data were abstracted. Data regarding the primary objective included the oral morphine milligram equivalents of opioid prescribed and used after discharge. Information meeting criteria for the secondary objectives was collected, and qualitative data synthesis was performed to generate evidence-based practice guidelines for prescription of opioids after FPMRS procedures.</p><p><strong>Results: </strong>A total of 6,028 unique abstracts were identified, 452 were screened, and 198 full-text articles were assessed for eligibility. Fifteen articles informed the primary outcome, and 32 informed secondary outcomes.</p><p><strong>Conclusions: </strong>For opioid-naive patients undergoing pelvic reconstructive surgery, we strongly recommend surgeons to provide no more than 15 tablets of opioids (roughly 112.5 morphine milligram equivalents) on hospital discharge. In cases where patients use no or little opioids in the hospital, patients may be safely discharged without postoperative opioids. Second, patient and surgical factors that may have an impact on opioid use should be assessed before surgery. Third, enhanced recovery pathways should be used to improve perioperative care, optimize pain control, and minimize opioid use. Fourth, systemic issues that lead to opioid overprescribing should be addressed. Female pelvic medicine and reconstructive surgery surgeons must aim to balance adequate postoperative pain control with individual and societal risks associated with excess opioid prescribing.</p>","PeriodicalId":48831,"journal":{"name":"Female Pelvic Medicine and Reconstructive Surgery","volume":"27 11","pages":"643-653"},"PeriodicalIF":1.6,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39533880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Female Pelvic Medicine and Reconstructive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1